Greenwich Lifesciences Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +300.5% | -75.4% | +107,419.8% | -5.1% | -50.5% | -48.1% | -41.5% | +50.9% | |
| – | +157,496.3% | -92.0% | +419,217.8% | -5.1% | -50.5% | -48.1% | -41.5% | +51.0% | |
| – | +157,496.3% | -92.0% | +419,217.8% | -5.1% | -50.5% | -48.1% | -41.5% | +51.0% | |
| – | +157,496.3% | -92.0% | +419,217.8% | -5.1% | -50.5% | -48.1% | -41.5% | +51.0% | |
| – | – | -15.4% | -18.2% | -22.3% | -28.6% | -40.1% | -67.0% | – | |
| – | +19.5% | -86.5% | -24.1% | -63.2% | -31.7% | +12.0% | +981.9% | +82.9% | |
| – | +30.7% | +89.0% | -24.1% | -63.2% | -31.7% | +12.0% | +981.9% | +82.9% | |
| – | – | – | -56.7% | – | – | – | – | – | |
| – | +72.2% | +163.1% | -2.6% | -68.9% | +0.0% | -83.9% | +7,801.9% | +73.9% | |
| – | – | – | – | -2.9% | -50.8% | -49.3% | -86.4% | -61.1% | |
| – | – | – | – | – | – | – | – | – | |
| – | +1.9% | -1.9% | +8.2% | +1.9% | -0.2% | -0.5% | +1.3% | +4.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.